1) Glypican-3
磷脂酰肌醇蛋白多糖-3
1.
Glypican-3 expression and its correlation with clinicopathological parameters in hepatocellular carcinoma
磷脂酰肌醇蛋白多糖-3在肝癌组织中的表达及其临床病理学特征
2) glypican-3
磷脂酰肌醇蛋白聚糖-3
1.
CONCLUSION:The effector cells stimulated with DCs that are transfected with pEF-hGPC3 plasmid can effectively lyse glypican-3 expressing HepG2 cells,which suggests that those genetically engineered DCs have the potential to serve as a novel vaccine for HCC.
方法:从HLA-A2正常健康成人外周血分离单个核细胞,经GM-CSF和IL-4诱导产生DCs;通过脂质体转染法将携带人GPC3基因的质粒pEF-hG-PC3转染DCs,蛋白质印迹法检测磷脂酰肌醇蛋白聚糖-3表达,流式细胞仪检测DCs表型的变化;MTT法检测DC诱导CTL对人肝癌细胞HepG2的特异性杀伤。
3) Glypican-3
磷脂酰肌醇蛋白聚糖3
1.
As one of the members of heparan sulfate proteoglycans,Glypican-3 (GPC3) participates in the process of cell proliferation,differentiation,adhesion and migration.
磷脂酰肌醇蛋白聚糖3是硫酸乙酰肝素糖蛋白家族中的一员,它参与调控细胞增殖、分化、黏附和迁移等过程。
4) glypican-3(GPC3)
磷脂酰肌醇硫酸类肝素蛋白聚糖-3(GPC3)
5) glypican-3
磷脂酰肌醇蛋白聚糖3(GPC3)
6) glycosylphosphatidylinositol anchored proteins
糖基磷脂酰肌醇锚蛋白
1.
Objective:To investigate the expression of glycosylphosphatidylinositol anchored proteins(GPI AP:CD55,CD59) on peripheral erythrocytes and granulocytes in patients with myelodysplastic syndrome(MDS).
目的 :探讨糖基磷脂酰肌醇锚蛋白 (GPI AP)在骨髓增生异常综合征 (MDS)患者外周血细胞上的表达情况。
补充资料:云芝多糖K,云芝胞内多糖,蛋白多糖体PSK
药物名称:蛋白多糖体PSK
英文名:Krestin
别名:云芝多糖K,云芝胞内多糖,蛋白多糖体PSK
作用与特点:为较好的抗肿瘤免疫剂,并能增强细胞免疫功能.用于辅助治疗消化道肉瘤,肺癌及乳腺癌等肿瘤,有改善症状的效果.
用法用量:口服:3g,1/d,连服数月,剂量可视症状增减.
规格:片剂:1g.
类别:免疫增强剂(免疫反应调节剂)
英文名:Krestin
别名:云芝多糖K,云芝胞内多糖,蛋白多糖体PSK
作用与特点:为较好的抗肿瘤免疫剂,并能增强细胞免疫功能.用于辅助治疗消化道肉瘤,肺癌及乳腺癌等肿瘤,有改善症状的效果.
用法用量:口服:3g,1/d,连服数月,剂量可视症状增减.
规格:片剂:1g.
类别:免疫增强剂(免疫反应调节剂)
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条